On the public citation graph
Network analytics for drug repurposing in COVID-19
0 signed · 115 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/jmv.26222openalex-snapshot
SARS‐CoV‐2 and SARS‐CoV: Virtual screening of potential inhibitors targeting RNA‐dependent RNA polymerase activity (NSP12)
inferredcites →https://doi.org/10.1007/s40203-020-00071-wopenalex-snapshot
In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (Mpro)
inferredcites →https://doi.org/10.1016/j.cell.2020.10.030openalex-snapshot
Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells
inferredcites →https://doi.org/10.1016/j.cell.2020.11.007openalex-snapshot
Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques
inferredcites →https://doi.org/10.1016/j.cellimm.2015.01.018openalex-snapshot
Estrogen receptors regulate innate immune cells and signaling pathways
inferredcites →https://doi.org/10.1016/j.compbiomed.2020.104051openalex-snapshot
Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19
inferredcites →https://doi.org/10.1016/j.ijbiomac.2020.12.038openalex-snapshot
Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs
inferredcites →https://doi.org/10.1016/j.jcv.2020.104362openalex-snapshot
Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
inferredcites →https://doi.org/10.1016/j.meegid.2020.104610openalex-snapshot
A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection
inferredcites →https://doi.org/10.1016/j.micpath.2020.104241openalex-snapshot
Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19)
inferredcites →https://doi.org/10.1016/j.molcel.2020.08.006openalex-snapshot
Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication
inferredcites →https://doi.org/10.1016/j.phrs.2020.104808openalex-snapshot
Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19)
inferredcites →https://doi.org/10.1016/j.phrs.2020.104859openalex-snapshot
Candidate drugs against SARS-CoV-2 and COVID-19
inferredcites →https://doi.org/10.1016/j.rechem.2020.100094openalex-snapshot
In-silico drug repurposing study: Amprenavir, enalaprilat, and plerixafor, potential drugs for destabilizing the SARS-CoV-2 S-protein-angiotensin-converting enzyme 2 complex
inferredcites →https://doi.org/10.1016/s1473-3099(20)30120-1openalex-snapshot
An interactive web-based dashboard to track COVID-19 in real time
inferredcites →https://doi.org/10.1016/s2213-2600(20)30079-5openalex-snapshot
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
inferredcites →https://doi.org/10.1017/s0007114520003979openalex-snapshot
Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Coronavirus disease 2019
inferredcites →https://doi.org/10.1021/acs.jpclett.0c02421openalex-snapshot
Discovery of COVID-19 Inhibitors Targeting the SARS-CoV‑2 Nsp13 Helicase
inferredcites →https://doi.org/10.1021/acs.jproteome.0c00383openalex-snapshot
In Silico Drug Repurposing for SARS-CoV‑2 Main Proteinase and Spike Proteins
inferredcites →https://doi.org/10.1021/acsinfecdis.0c00486openalex-snapshot
High-Throughput Screening of an FDA-Approved Drug Library Identifies Inhibitors against Arenaviruses and SARS-CoV-2
inferredcites →https://doi.org/10.1038/75556openalex-snapshot
Gene Ontology: tool for the unification of biology
inferredcites →https://doi.org/10.1038/nature10011openalex-snapshot
Controllability of complex networks
inferredcites →https://doi.org/10.1038/nature24056openalex-snapshot
Network control principles predict neuron function in the Caenorhabditis elegans connectome
inferredcites →https://doi.org/10.1038/nmeth.4077openalex-snapshot
OmniPath: guidelines and gateway for literature-curated signaling pathway resources
inferredcites →https://doi.org/10.1038/s41467-020-17189-2openalex-snapshot
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
inferredcites →https://doi.org/10.1038/s41586-020-2286-9openalex-snapshot
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
inferredcites →https://doi.org/10.1038/s41586-021-03493-4openalex-snapshot
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
inferredcites →https://doi.org/10.1038/s41597-021-00848-4openalex-snapshot
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection
inferredcites →https://doi.org/10.1038/s41598-020-70863-9openalex-snapshot
An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors
inferredcites →https://doi.org/10.1038/s42005-021-00582-8openalex-snapshot
Multiscale statistical physics of the pan-viral interactome unravels the systemic nature of SARS-CoV-2 infections
inferredcites →https://doi.org/10.1039/d0mo00057dopenalex-snapshot
Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data
inferredcites →https://doi.org/10.1056/nejmsa1012065openalex-snapshot
The ClinicalTrials.gov Results Database — Update and Key Issues
inferredcites →https://doi.org/10.1073/pnas.2025581118openalex-snapshot
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
inferredcites →https://doi.org/10.1073/pnas.2105815118openalex-snapshot
Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19
inferredcites →https://doi.org/10.1080/07391102.2020.1784291openalex-snapshot
Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease
inferredcites →https://doi.org/10.1080/07391102.2020.1809522openalex-snapshot
An in-silico evaluation of dietary components for structural inhibition of SARS-Cov-2 main protease
inferredcites →https://doi.org/10.1080/07391102.2020.1828172openalex-snapshot
Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus
inferredcites →https://doi.org/10.1080/07391102.2020.1835721openalex-snapshot
High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein
inferredcites →https://doi.org/10.1080/07391102.2020.1835732openalex-snapshot
Caffeine and caffeine-containing pharmaceuticals as promising inhibitors for 3-chymotrypsin-like protease of SARS-CoV-2
inferredcites →https://doi.org/10.1080/07391102.2020.1862705openalex-snapshot
Identification of potential non-nucleoside MraY inhibitors for tuberculosis chemotherapy using structure-based virtual screening
inferredcites →https://doi.org/10.1080/07391102.2020.1863265openalex-snapshot
Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing
inferredcites →https://doi.org/10.1080/13543776.2020.1772231openalex-snapshot
SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review
inferredcites →https://doi.org/10.1080/22221751.2020.1799723openalex-snapshot
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
inferredcites →https://doi.org/10.1089/nsm.2020.0011openalex-snapshot
CovMulNet19, Integrating Proteins, Diseases, Drugs, and Symptoms: A Network Medicine Approach to COVID-19
inferredcites →https://doi.org/10.1093/bib/bbaa417openalex-snapshot
Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment
inferredcites →https://doi.org/10.1093/bioinformatics/btab570openalex-snapshot
NetControl4BioMed: a web-based platform for controllability analysis of protein–protein interaction networks
inferredcites →https://doi.org/10.1093/gerona/glab002openalex-snapshot
Senolytic Combination of Dasatinib and Quercetin Alleviates Intestinal Senescence and Inflammation and Modulates the Gut Microbiome in Aged Mice
inferredcites →https://doi.org/10.1093/nar/27.1.29openalex-snapshot
KEGG: Kyoto Encyclopedia of Genes and Genomes
inferredcites →https://doi.org/10.1093/nar/28.1.27openalex-snapshot
KEGG: Kyoto Encyclopedia of Genes and Genomes
inferredcites →https://doi.org/10.1093/nar/gkaa1100openalex-snapshot
UniProt: the universal protein knowledgebase in 2021
inferredcites →https://doi.org/10.1093/nar/gkaa1113openalex-snapshot
The Gene Ontology resource: enriching a GOld mine
inferredcites →https://doi.org/10.1093/nar/gkaa1272openalex-snapshot
Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients
inferredcites →https://doi.org/10.1093/nar/gkx1037openalex-snapshot
DrugBank 5.0: a major update to the DrugBank database for 2018
inferredcites →https://doi.org/10.1093/nar/gky1038openalex-snapshot
PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools
inferredcites →https://doi.org/10.1093/nar/gkz949openalex-snapshot
SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update
inferredcites →https://doi.org/10.1093/rheumatology/keaa587openalex-snapshot
Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study
inferredcites →https://doi.org/10.1101/2020.06.04.135046openalex-snapshot
Real-time sharing of drug screening data on the NCATS OpenData Portal accelerates translational research
inferredcites →https://doi.org/10.1109/tcbb.2018.2797271openalex-snapshot
Structural Target Controllability of Linear Networks
inferredcites →https://doi.org/10.1111/bcpt.13537openalex-snapshot
The tyrosine kinase inhibitor nilotinib inhibits SARS‐CoV‐2 in vitro
inferredcites →https://doi.org/10.1111/cas.14618openalex-snapshot
RNA‐dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID‐19
inferredcites →https://doi.org/10.1111/j.1756-5391.2009.01002.xopenalex-snapshot
Iranian Registry of Clinical Trials: path and challenges from conception to a World Health Organization primary register
inferredcites →https://doi.org/10.1111/jth.14849openalex-snapshot
Thromboinflammation and the hypercoagulability of COVID‐19
inferredcites →https://doi.org/10.1126/science.abe9403openalex-snapshot
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
inferredcites →https://doi.org/10.1128/aac.00754-20openalex-snapshot
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
inferredcites →https://doi.org/10.1128/jvi.01218-20openalex-snapshot
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo
inferredcites →https://doi.org/10.1158/1078-0432.ccr-21-0553openalex-snapshot
Network Analysis Reveals Synergistic Genetic Dependencies for Rational Combination Therapy in Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia
inferredcites →https://doi.org/10.1172/jci141772openalex-snapshot
Baricitinib restrains the immune dysregulation in patients with severe COVID-19
inferredcites →https://doi.org/10.1186/s12916-020-01851-zopenalex-snapshot
Evidence for treatment with estradiol for women with SARS-CoV-2 infection
inferredcites →https://doi.org/10.18632/oncotarget.5156openalex-snapshot
Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia
inferredcites →https://doi.org/10.3389/fmicb.2020.01796openalex-snapshot
Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis
inferredcites →https://doi.org/10.3389/fphar.2019.00400openalex-snapshot
Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5
inferredcites →https://doi.org/10.3389/fphar.2020.00857openalex-snapshot
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study
inferredcites →https://doi.org/10.3390/antibiotics10010092openalex-snapshot
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics
inferredcites →https://doi.org/10.3390/computation8020053openalex-snapshot
Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease
inferredcites →https://doi.org/10.3390/computation8030077openalex-snapshot
Exploring the SARS-CoV-2 Proteome in the Search of Potential Inhibitors via Structure-Based Pharmacophore Modeling/Docking Approach
inferredcites →https://doi.org/10.3390/ijms21082948openalex-snapshot
Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
inferredcites →https://doi.org/10.3390/ijms21134782openalex-snapshot
Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications
inferredcites →https://doi.org/10.3390/jcm9051473openalex-snapshot
Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site
inferredcites →https://doi.org/10.3390/molecules25112529openalex-snapshot
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus
inferredcites →https://doi.org/10.3390/molecules25143193openalex-snapshot
High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2
inferredcites →https://doi.org/10.3390/v12060629openalex-snapshot
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner
inferredcites →https://doi.org/10.3390/v12060642openalex-snapshot
Potential Antiviral Options against SARS-CoV-2 Infection
inferredcites →https://doi.org/10.3390/v13020282openalex-snapshot
Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro
inferredcites →https://doi.org/10.34172/jrcm.2020.044openalex-snapshot
Sirolimus to treat SARS-CoV-2 infection: an old drug for a new disease
inferredcites →https://doi.org/10.4103/ijo.ijo_639_20openalex-snapshot
Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future
inferredcites →https://doi.org/10.7717/peerj.9965openalex-snapshot
Potential COVID-19 papain-like protease PL pro inhibitors: repurposing FDA-approved drugs
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/9781394168033.ch3openalex-snapshot
Ivermectin as a Repurposed Drug for COVID‐19
inferred← citeshttps://doi.org/10.1007/978-981-19-5399-6_18openalex-snapshot
Repurposing Drugs for Viruses and Cancer: A Novel Drug Repositioning Strategy for COVID-19
inferred← citeshttps://doi.org/10.1007/s11224-022-01999-9openalex-snapshot
Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics
inferred← citeshttps://doi.org/10.1016/b978-0-443-29808-0.00021-2openalex-snapshot
Connectivity mapping: Integrating omics data, drug targets, and disease drivers for drug discovery and repurposing
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2024.03.020openalex-snapshot
Current approaches in identification of a novel drug targets for drug repurposing
inferred← citeshttps://doi.org/10.1016/j.drudis.2025.104499openalex-snapshot
From matrix factorization to graph neural networks: Advances in computational drug repositioning
inferred← citeshttps://doi.org/10.1016/j.isci.2022.105348openalex-snapshot
Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference
inferred← citeshttps://doi.org/10.1016/j.prp.2023.154311openalex-snapshot
Role of different types of RNA molecules in the severity prediction of SARS-CoV-2 patients
inferred← citeshttps://doi.org/10.1016/j.trac.2024.118023openalex-snapshot
New revolution for quality control of TCM in industry 4.0: Focus on artificial intelligence and bioinformatics
inferred← citeshttps://doi.org/10.1038/s41598-022-05335-3openalex-snapshot
Network controllability solutions for computational drug repurposing using genetic algorithms
inferred← citeshttps://doi.org/10.1051/bioconf/202623301005openalex-snapshot
Integrative Multi-Omics and Network Biology Approaches to Understanding Viral-Host Interactions in Neurodegenerative Diseases: From Pathogenesis to Therapeutic Targets
inferred← citeshttps://doi.org/10.1080/15384101.2024.2340859openalex-snapshot
Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks
inferred← citeshttps://doi.org/10.1186/s13062-023-00410-9openalex-snapshot
Total network controllability analysis discovers explainable drugs for Covid-19 treatment
inferred← citeshttps://doi.org/10.1186/s13321-021-00553-9openalex-snapshot
Using informative features in machine learning based method for COVID-19 drug repurposing
inferred← citeshttps://doi.org/10.12688/f1000research.109017.1openalex-snapshot
Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies
inferred← citeshttps://doi.org/10.1371/journal.pcbi.1014785openalex-snapshot
In-silico personalized protein–protein interaction networks prioritize candidate compounds for glioblastoma
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1285345openalex-snapshot
Signaling network analysis reveals fostamatinib as a potential drug to control platelet hyperactivation during SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.3389/fphar.2023.1182465openalex-snapshot
A review of SARS-CoV-2 drug repurposing: databases and machine learning models
inferred← citeshttps://doi.org/10.3390/ijms25168917openalex-snapshot
Drug Repurposing for COVID-19 by Constructing a Comorbidity Network with Central Nervous System Disorders
inferred← citeshttps://doi.org/10.3390/jpm13040664openalex-snapshot
Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease
inferred← citeshttps://doi.org/10.3390/medicina61091640openalex-snapshot
Redefining Breast Cancer Care by Harnessing Computational Drug Repositioning
inferred← citeshttps://doi.org/10.3390/microorganisms11082039openalex-snapshot
COVID Variants, Villain and Victory: A Bioinformatics Perspective
inferred← citeshttps://doi.org/10.3390/ph15070872openalex-snapshot
New Life of an Old Drug: Caffeine as a Modulator of Antibacterial Activity of Commonly Used Antibiotics
inferred← citeshttps://doi.org/10.3390/su152215768openalex-snapshot
TiO2/Arabic Gum for Degradation of Pollutants in Water
inferred← citeshttps://doi.org/10.4308/hjb.30.4.632-642openalex-snapshot
Chemical Composition, Antioxidant, Antibacterial, Antibiofilm, and Cytotoxic Activities of Robusta Coffee Extract (Coffea canephora)
inferred← citeshttps://doi.org/10.51847/lp8n72wfgiopenalex-snapshot
Recent Advances in Novel Inhibitor Molecules Development Targeting RNA Helicase (Nonstructural Protein 13) of SARS-CoV-2: Review
inferred← citeshttps://doi.org/10.58873/sict.v1i1.31openalex-snapshot
Biomolecular Network-based Study of a Parasitic Disease and Therapeutic Drugs
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.